Skip to main content
. 2022 Jun 3;13:877896. doi: 10.3389/fimmu.2022.877896

Figure 1.

Figure 1

Developments and validations of the C3 immune subtype (IS) (A) Flowchart of developments and validations of the C3 immune subtype (IS). Overall survival (OS) (B) and progression-free interval event (PFI) (C) by immune subtypes (C3 vs. Other ISs) in TCGA LUAD cohort (n = 457) to verify the relationship between the C3 IS and prognosis. P-value was calculated by log-rank test.